Cargando…
Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission
BACKGROUND: Galectin-3 (Gal-3) is a proinflammatory and profibrotic protein especially overexpressed after Acute Kidney Injury (AKI). The early renal prognostic value of Gal-3 after AKI in critically ill patients remains unexplored. The objective was to evaluate the prognostic value of plasma level...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740042/ https://www.ncbi.nlm.nih.gov/pubmed/34991653 http://dx.doi.org/10.1186/s13054-021-03878-x |
_version_ | 1784629229180157952 |
---|---|
author | Boutin, L. Legrand, M. Sadoune, M. Mebazaa, A. Gayat, E. Chadjichristos, C. E. Dépret, F. |
author_facet | Boutin, L. Legrand, M. Sadoune, M. Mebazaa, A. Gayat, E. Chadjichristos, C. E. Dépret, F. |
author_sort | Boutin, L. |
collection | PubMed |
description | BACKGROUND: Galectin-3 (Gal-3) is a proinflammatory and profibrotic protein especially overexpressed after Acute Kidney Injury (AKI). The early renal prognostic value of Gal-3 after AKI in critically ill patients remains unexplored. The objective was to evaluate the prognostic value of plasma level of Gal-3 for Major Adverse Kidney Events (MAKE) and mortality 30 days after ICU admission across AKI stages. METHODS: This is an ancillary study of a prospective, observational, multicenter cohort (FROG-ICU). AKI was defined using KDIGO definition. RESULTS: Two thousand and seventy-six patients had a Gal-3 plasma level measurement at ICU admission. Seven hundred and twenty-three (34.8%) were females and the median age was 63 [51, 74] years. Eight hundred and seven (38.9%) patients developed MAKE, 774 (37.3%) had AKI and mortality rate at 30 days was 22.4% (N = 465). Patients who developed MAKE had higher Gal-3 level at admission compared to patients without (30.2 [20.8, 49.2] ng/ml versus 16.9 [12.7, 24.3] ng/ml, p < 0.001, respectively. The area under the receiver operating characteristic curve of Gal-3 to predict MAKE was 0.76 CI(95%) [0.74–0.78], p < 0.001. Gal-3 was associated with MAKE (OR 1.80 CI(95%) [1.68–1.93], p < 0.001, non-adjusted and OR 1.37 CI(95%) [1.27–1.49], p < 0.001, adjusted). The use of Gal-3 improved prediction performance of prediction model including SAPSII, Screat(adm), pNGAL with a NRI of 0.27 CI(95%)(0.16–0.38), p < 0.001. Median Gal-3 was higher in non-survivors than in survivors at 30 days (29.2 [20.2, 49.2] ng/ml versus 18.8 [13.3, 29.2] ng/ml, p < 0.001, respectively). CONCLUSION: Plasma levels of Gal-3 were strongly associated with renal function, with an increased risk of MAKE and death after ICU admission. Trial registration ClinicalTrials.gov NCT01367093. Registered on 6 June 2011. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03878-x. |
format | Online Article Text |
id | pubmed-8740042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87400422022-01-07 Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission Boutin, L. Legrand, M. Sadoune, M. Mebazaa, A. Gayat, E. Chadjichristos, C. E. Dépret, F. Crit Care Research BACKGROUND: Galectin-3 (Gal-3) is a proinflammatory and profibrotic protein especially overexpressed after Acute Kidney Injury (AKI). The early renal prognostic value of Gal-3 after AKI in critically ill patients remains unexplored. The objective was to evaluate the prognostic value of plasma level of Gal-3 for Major Adverse Kidney Events (MAKE) and mortality 30 days after ICU admission across AKI stages. METHODS: This is an ancillary study of a prospective, observational, multicenter cohort (FROG-ICU). AKI was defined using KDIGO definition. RESULTS: Two thousand and seventy-six patients had a Gal-3 plasma level measurement at ICU admission. Seven hundred and twenty-three (34.8%) were females and the median age was 63 [51, 74] years. Eight hundred and seven (38.9%) patients developed MAKE, 774 (37.3%) had AKI and mortality rate at 30 days was 22.4% (N = 465). Patients who developed MAKE had higher Gal-3 level at admission compared to patients without (30.2 [20.8, 49.2] ng/ml versus 16.9 [12.7, 24.3] ng/ml, p < 0.001, respectively. The area under the receiver operating characteristic curve of Gal-3 to predict MAKE was 0.76 CI(95%) [0.74–0.78], p < 0.001. Gal-3 was associated with MAKE (OR 1.80 CI(95%) [1.68–1.93], p < 0.001, non-adjusted and OR 1.37 CI(95%) [1.27–1.49], p < 0.001, adjusted). The use of Gal-3 improved prediction performance of prediction model including SAPSII, Screat(adm), pNGAL with a NRI of 0.27 CI(95%)(0.16–0.38), p < 0.001. Median Gal-3 was higher in non-survivors than in survivors at 30 days (29.2 [20.2, 49.2] ng/ml versus 18.8 [13.3, 29.2] ng/ml, p < 0.001, respectively). CONCLUSION: Plasma levels of Gal-3 were strongly associated with renal function, with an increased risk of MAKE and death after ICU admission. Trial registration ClinicalTrials.gov NCT01367093. Registered on 6 June 2011. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03878-x. BioMed Central 2022-01-06 /pmc/articles/PMC8740042/ /pubmed/34991653 http://dx.doi.org/10.1186/s13054-021-03878-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Boutin, L. Legrand, M. Sadoune, M. Mebazaa, A. Gayat, E. Chadjichristos, C. E. Dépret, F. Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title | Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title_full | Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title_fullStr | Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title_full_unstemmed | Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title_short | Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission |
title_sort | elevated plasma galectin-3 is associated with major adverse kidney events and death after icu admission |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740042/ https://www.ncbi.nlm.nih.gov/pubmed/34991653 http://dx.doi.org/10.1186/s13054-021-03878-x |
work_keys_str_mv | AT boutinl elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT legrandm elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT sadounem elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT mebazaaa elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT gayate elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT chadjichristosce elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission AT depretf elevatedplasmagalectin3isassociatedwithmajoradversekidneyeventsanddeathaftericuadmission |